154 related articles for article (PubMed ID: 37741350)
21. Cardiac Phenotypes and Markers of Adverse Outcome in Elite Athletes With Ventricular Arrhythmias.
Lie ØH; Klaboe LG; Dejgaard LA; Skjølsvik ET; Grimsmo J; Bosse G; Hopp E; Edvardsen T; Haugaa KH
JACC Cardiovasc Imaging; 2021 Jan; 14(1):148-158. PubMed ID: 33129723
[TBL] [Abstract][Full Text] [Related]
22. Exercise and the heart: the good, the bad, and the ugly.
Sharma S; Merghani A; Mont L
Eur Heart J; 2015 Jun; 36(23):1445-53. PubMed ID: 25839670
[TBL] [Abstract][Full Text] [Related]
23. Differentiation between athlete's heart and dilated cardiomyopathy in athletic individuals.
Millar LM; Fanton Z; Finocchiaro G; Sanchez-Fernandez G; Dhutia H; Malhotra A; Merghani A; Papadakis M; Behr ER; Bunce N; Oxborough D; Reed M; O'Driscoll J; Tome Esteban MT; D'Silva A; Carr-White G; Webb J; Sharma R; Sharma S
Heart; 2020 Jul; 106(14):1059-1065. PubMed ID: 32341137
[TBL] [Abstract][Full Text] [Related]
24. Prevalence and pattern of focal and potential diffuse myocardial fibrosis in male and female marathon runners using contrast-enhanced cardiac magnetic resonance.
Ragab H; Lund GK; Breitsprecher L; Sinn MR; Muellerleile K; Cavus E; Stehning C; Tahir E; Blankenberg S; Patten M; Pressler A; Adam G; Avanesov M
Eur Radiol; 2023 Jul; 33(7):4648-4656. PubMed ID: 36683089
[TBL] [Abstract][Full Text] [Related]
25. Absence of cardiac damage induced by long-term intensive endurance exercise training: A cardiac magnetic resonance and exercise echocardiography analysis in masters athletes.
Missenard O; Gabaudan C; Astier H; Desmots F; Garnotel E; Massoure PL
Am J Prev Cardiol; 2021 Sep; 7():100196. PubMed ID: 34611636
[TBL] [Abstract][Full Text] [Related]
26. Importance of cardiac magnetic resonance findings in the diagnosis of left dominant arrythmogenic cardiomyopathy.
Feliu E; Moscicki R; Carrillo L; García-Fernández A; Martínez Martínez JG; Ruiz-Nodar JM
Rev Esp Cardiol (Engl Ed); 2020 Nov; 73(11):885-892. PubMed ID: 31992505
[TBL] [Abstract][Full Text] [Related]
27. Cardiac magnetic resonance imaging for the detection of myocardial involvement in granulomatosis with polyangiitis.
Giollo A; Dumitru RB; Swoboda PP; Plein S; Greenwood JP; Buch MH; Andrews J
Int J Cardiovasc Imaging; 2021 Mar; 37(3):1053-1062. PubMed ID: 33057879
[TBL] [Abstract][Full Text] [Related]
28. Impact of ethnicity upon cardiovascular adaptation in competitive athletes: relevance to preparticipation screening.
Papadakis M; Wilson MG; Ghani S; Kervio G; Carre F; Sharma S
Br J Sports Med; 2012 Nov; 46 Suppl 1():i22-8. PubMed ID: 22844038
[TBL] [Abstract][Full Text] [Related]
29. Myocardial Fibrosis in Competitive Triathletes Detected by Contrast-Enhanced CMR Correlates With Exercise-Induced Hypertension and Competition History.
Tahir E; Starekova J; Muellerleile K; von Stritzky A; Münch J; Avanesov M; Weinrich JM; Stehning C; Bohnen S; Radunski UK; Freiwald E; Blankenberg S; Adam G; Pressler A; Patten M; Lund GK
JACC Cardiovasc Imaging; 2018 Sep; 11(9):1260-1270. PubMed ID: 29248656
[TBL] [Abstract][Full Text] [Related]
30. The demanding grey zone: Sport indices by cardiac magnetic resonance imaging differentiate hypertrophic cardiomyopathy from athlete's heart.
Czimbalmos C; Csecs I; Toth A; Kiss O; Suhai FI; Sydo N; Dohy Z; Apor A; Merkely B; Vago H
PLoS One; 2019; 14(2):e0211624. PubMed ID: 30763323
[TBL] [Abstract][Full Text] [Related]
31. Cardiac magnetic resonance based deformation imaging: role of feature tracking in athletes with suspected arrhythmogenic right ventricular cardiomyopathy.
Czimbalmos C; Csecs I; Dohy Z; Toth A; Suhai FI; Müssigbrodt A; Kiss O; Geller L; Merkely B; Vago H
Int J Cardiovasc Imaging; 2019 Mar; 35(3):529-538. PubMed ID: 30382474
[TBL] [Abstract][Full Text] [Related]
32. Multimodality Imaging Assessment of Myocardial Fibrosis.
Gupta S; Ge Y; Singh A; Gräni C; Kwong RY
JACC Cardiovasc Imaging; 2021 Dec; 14(12):2457-2469. PubMed ID: 34023250
[TBL] [Abstract][Full Text] [Related]
33. Synthetic late gadolinium enhancement cardiac magnetic resonance for diagnosing myocardial scar.
Abdula G; Nickander J; Sörensson P; Lundin M; Kellman P; Sigfridsson A; Ugander M
Scand Cardiovasc J; 2018 Jun; 52(3):127-132. PubMed ID: 29544374
[TBL] [Abstract][Full Text] [Related]
34. The impact of sex, age and training on biventricular cardiac adaptation in healthy adult and adolescent athletes: Cardiac magnetic resonance imaging study.
Csecs I; Czimbalmos C; Toth A; Dohy Z; Suhai IF; Szabo L; Kovacs A; Lakatos B; Sydo N; Kheirkhahan M; Peritz D; Kiss O; Merkely B; Vago H
Eur J Prev Cardiol; 2020 Mar; 27(5):540-549. PubMed ID: 31370686
[TBL] [Abstract][Full Text] [Related]
35. Hypertrophic cardiomyopathy or athlete's heart? A systematic review of novel cardiovascular magnetic resonance imaging parameters.
Bakogiannis C; Mouselimis D; Tsarouchas A; Papatheodorou E; Vassilikos VP; Androulakis E
Eur J Sport Sci; 2023 Jan; 23(1):143-154. PubMed ID: 34720041
[TBL] [Abstract][Full Text] [Related]
36. Sudden cardiac death in athletes and the value of cardiovascular magnetic resonance.
Mavrogeni SI; Bacopoulou F; Apostolaki D; Chrousos GP
Eur J Clin Invest; 2018 Jul; 48(7):e12955. PubMed ID: 29782639
[TBL] [Abstract][Full Text] [Related]
37. Myocardial remodelling and tissue characterisation by cardiovascular magnetic resonance (CMR) in endurance athletes.
Pujadas S; Doñate M; Li CH; Merchan S; Cabanillas A; Alomar X; Pons-Llado G; Serra-Grima R; Carreras F
BMJ Open Sport Exerc Med; 2018; 4(1):e000422. PubMed ID: 30498573
[TBL] [Abstract][Full Text] [Related]
38. Cardiac magnetic resonance imaging as a prognostic tool in patients with nonischemic cardiomyopathy.
Partington SL; Seabra LF; Kwong RY
Hosp Pract (1995); 2010 Nov; 38(4):75-82. PubMed ID: 21068530
[TBL] [Abstract][Full Text] [Related]
39. Myocardial Fibrosis as a Predictor of Ventricular Arrhythmias in Patients With Non-ischemic Cardiomyopathy.
Schiau C; Leucuța DC; Dudea SM; Manole S
In Vivo; 2021; 35(3):1677-1685. PubMed ID: 33910852
[TBL] [Abstract][Full Text] [Related]
40. Left ventricular diastolic filling patterns in competitive triathletes with and without myocardial fibrosis by cardiac magnetic resonance time-volume analysis.
Chen H; Jungesblut J; Saering D; Muellerleile K; Beitzen-Heineke A; Harms P; Erley J; Schoennagel B; Schneider JN; Cavus E; Fischer R; Lund GK; Adam G; Tahir E
Eur J Radiol; 2023 Jan; 158():110615. PubMed ID: 36434969
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
